Antimicrobial characterization of human β-defensin 3 derivatives

Antimicrobial Agents and Chemotherapy

Volumn 47, Issue 9, 2003, Pages 2804-2809

  Hoover, David M ^a   Wu, Zhibin ^b   Tucker, Kenneth ^a   Lu, Wuyuan ^b   Lubkowski, Jacek ^a  

^a NATIONAL CANCER INSTITUTE   (United States)

^b INSTITUTE OF HUMAN VIROLOGY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

4 AMINOBUTYRIC ACID; BETA DEFENSIN 3; CYSTEINE; HUMAN BETA DEFENSIN 3; HUMAN BETA DEFENSIN 3 ALPHA AMINOBUTYRIC ACID; HUMAN BETA DEFENSIN 3 DELTA10; HUMAN BETA DEFENSIN 3 DELTA8; PEPTIDE CHRG01; PEPTIDE CHRG02; PEPTIDE CHRG04; PEPTIDE CHRG06; PEPTIDE CHRG07; PEPTIDE DERIVATIVE; PEPTIDE STRC06; UNCLASSIFIED DRUG;

AMINO ACID SYNTHESIS; AMINO TERMINAL SEQUENCE; ANTIMICROBIAL ACTIVITY; ARTICLE; CANDIDA ALBICANS; CARBOXY TERMINAL SEQUENCE; CONTROLLED STUDY; DISULFIDE BOND; DRUG ACTIVITY; DRUG STRUCTURE; DRUG SYNTHESIS; ELECTRICITY; ENTEROCOCCUS FAECIUM; ESCHERICHIA COLI; NONHUMAN; PRIORITY JOURNAL; PSEUDOMONAS AERUGINOSA; STAPHYLOCOCCUS AUREUS; STRUCTURE ACTIVITY RELATION;

AMINO ACID SEQUENCE; ANTI-BACTERIAL AGENTS; ANTI-INFECTIVE AGENTS; BACTERIA; BETA-DEFENSINS; COLONY COUNT, MICROBIAL; FUNGI; HUMANS; MICROBIAL SENSITIVITY TESTS; MOLECULAR SEQUENCE DATA; STRUCTURE-ACTIVITY RELATIONSHIP;

EID: 0041923585     PISSN: 00664804     EISSN: None     Source Type: Journal    
DOI: 10.1128/AAC.47.9.2804-2809.2003     Document Type: Article

References (39)

1. Bensch, K. W., M. Raida, H. J. Magert, P. Schulz-Knappe, and W. G. Forssmann. 1995. hBD-1: a novel beta-defensin from human plasma. FEBS Lett. 368:331-335.
2. Blondelle, S. E., and K. Lohner. 2000. Combinatorial libraries: a tool to design antimicrobial and antifungal peptide analogues having lytic specificities for structure-activity relationship studies. Biopolymers 55:74-87.
3. Brissette, C. A., and S. A. Lukehart. 2002. Treponema denticola is resistant to human β-defensins. Infect. Immun. 70:3982-3984.
4. Cociancich, S., A. Ghazi, C. Hetru, J. A. Hoffmann, and L. Letellier. 1993. Insect defensin, an inducible antibacterial peptide, forms voltage-dependent channels in Micrococcus luteus. J. Biol. Chem. 268:19239-19245.
5. Fujii, G., M. E. Selsted, and D. Eisenberg. 1993. Defensins promote fusion and lysis of negatively charged membranes. Protein Sci. 2:1301-1312.
6. Ganz, T. 1999. Defensins and host defense. Science 286:420-421.
7. Ganz, T., M. E. Selsted, D. Szklarek, S. S. Harwig, K. Daher, D. F. Bainton, and R. I. Lehrer. 1985. Defensins: natural peptide antibiotics of human neutrophils. J. Clin. Investig. 76:1427-1435.
8. García, J. R., F. Jaumann, S. Schulz, A. Krause, J. Rodríguez-Jiménez, U. Forssmann, K. Adermann, E. Kluver, C. Vogelmeier, D. Becker, R. Hedrich, W. G. Forssmann, and R. Bals. 2001. Identification of a novel, multifunctional beta-defensin (human beta-defensin 3) with specific antimicrobial activity. Its interaction with plasma membranes of Xenopus oocytes and the induction of macrophage chemoattraction. Cell Tissue Res. 306:257-264.
9. García, J. R., A. Krause, S. Schulz, F. J. Rodríguez-Jiménez, E. Klüver, K. Adermann, U. Forssmann, A. Frimpong-Boateng, R. Bals, and W. G. Forssmann. 2001. Human β-defensin 4: a novel inducible peptide with a specific salt-sensitive spectrum of antimicrobial activity. FASEB J. 15:1819-1821.
10. Gera, J. F., and A. Lichtenstein. 1991. Human neutrophil peptide defensins induce single strand DNA breaks in target cells. Cell. Immunol. 138:108-120.
11. Gropp, R., M. Frye, T. O. Wagner, and J. Bargon. 1999. Epithelial defensins impair adenoviral infection: implication for adenovirus-mediated gene therapy. Hum. Gene Ther. 10:957-964.
12. Harder, J., J. Bartels, E. Christophers, and J. M. Schröder. 1997. A peptide antibiotic from human skin. Nature 387:861.
13. Harder, J., J. Bartels, E. Christophers, and J. M. Schröder. 2001. Isolation and characterization of human beta-defensin-3, a novel human inducible peptide antibiotic. J. Biol. Chem. 276:5707-5713.
14. Harwig, S. S., T. Ganz, and R. I. Lehrer. 1994. Neutrophil defensins: purification, characterization, and antimicrobial testing. Methods Enzymol. 236:160-172.
15. Hill, C. P., J. Yee, M. E. Selsted, and D. Eisenberg. 1991. Crystal structure of defensin HNP-3, an amphiphilic dimer: mechanisms of membrane permeabilization. Science 251:1481-1485.
16. Hoover, D. M., K. R. Rajashankar, R. Blumenthal, A. Puri, J. J. Oppenheim, O. Chertov, and J. Lubkowski. 2000. The structure of human beta-defensin-2 shows evidence of higher order oligomerization. J. Biol. Chem. 275:32911-32918.
17. Hristova, K., M. E. Selsted, and S. H. White. 1996. Interactions of monomeric rabbit neutrophil defensins with bilayers: comparison with dimeric human defensin HNP-2. Biochemistry 35:11888-11894.
18. Hristova, K., M. E. Selsted, and S. H. White. 1997. Critical role of lipid composition in membrane permeabilization by rabbit neutrophil defensins. J. Biol. Chem. 272:24224-24233.
19. Jia, H. P., B. C. Schutte, A. Schudy, R. Linzmeier, J. M. Guthmiller, G. K. Johnson, B. F. Tack, J. P. Mitros, A. Rosenthal, T. Ganz, and P. B. MeCray, Jr. 2001. Discovery of new human beta-defensins using a genomics-based approach. Gene 263:211-218.
20. Kagan, B. L., M. E. Selsted, T. Ganz, and R. I. Lehrer. 1990. Antimicrobial defensin peptides form voltage-dependent ion-permeable channels in planar lipid bilayer membranes. Proc. Natl. Acad. Sci. USA 87:210-214.
21. Maget-Dana, R., and M. Ptak. 1997. Penetration of the insect defensin A into phospholipid monolayers and formation of defensin A-lipid complexes. Biophys. J. 73:2527-2533.
22. Mandal, M., M. V. Jagannadham, and R. Nagaraj. 2002. Antibacterial activities and conformations of bovine beta-defensin BNBD-12 and analogs: structural and disulfide bridge requirements for activity. Peptides 23:413-418.
23. Merlin, D., G. Yue, W. I. Lencer, M. E. Selsted, and J. L. Madara. 2001. Cryptdin-3 induces novel apical conductance(s) in Cl- secretory, including cystic fibrosis, epithelia. Am. J. Physiol. Cell Physiol. 280:C296-C302.
24. Peschel, A., M. Otto, R. W. Jack, H. Kalbacher, G. Jung, and F. Gotz. 1999. Inactivation of the dlt operon in Staphylococcus aureus confers sensitivity to defensins, protegrins, and other antimicrobial peptides. J. Biol. Chem. 274:8405-8410.
25. Porter, E. M., E. van Dam, E. V. Valore, and T. Ganz. 1997. Broad-spectrum antimicrobial activity of human intestinal defensin 5. Infect. Immun. 65:2396-2401.
26. Raj, P. A., and A. R. Dentino. 2002. Current status of defensins and their role in innate and adaptive immunity. FEMS Microbiol. Lett. 206:9-18.
27. Schibli, D. J., H. N. Hunter, V. Aseyev, T. D. Starner, J. M. Wiencek, P. B. McCray, Jr., B. F. Tack, and H. J. Vogel. 2002. The solution structures of the human beta-defensins lead to a better understanding of the potent bactericidal activity of HBD3 against Staphylococcus aureus. J. Biol. Chem. 277:8279-8289.
28. Schnölzer, M., P. Alewood, A. Jones, D. Alewood, and S. B. H. Kent. 1992. In situ neutralization in Boc-chemistry solid phase peptide synthesis. J. Peptide Protein Res. 40:180-193.
29. Sharma, S., and G. Khuller. 2001. DNA as the intracellular secondary target for antibacterial action of human neutrophil peptide-I against Mycobacterium tuberculosis H37Ra. Curr. Microbiol. 43:74-76.
30. Starner, T. D., W. E. Swords, M. A. Apicella, and P. B. McCray, Jr. 2002. Susceptibility of nontypeable Haemophilus influenzae to human β-defensins is influenced by lipooligosaccharide acylation. Infect. Immun. 70:5287-5289.
31. Tam, J. P., Y. A. Lu, and Q. Yu. 1999. Thia Zip reaction for synthesis of large cyclic peptides: mechanisms and applications. J. Am. Chem. Soc. 121:4316-4324.
32. Tang, Y. Q., J. Yuan, G. Osapay, K. Osapay, D. Tran, C. J. Miller, A. J. Ouellette, and M. E. Selsted. 1999. A cyclic antimicrobial peptide produced in primate leukocytes by the ligation of two truncated α-defensins. Science 286:498-502.
33. Thevissen, K., R. W. Osborn, D. P. Acland, and W. F. Broekaert. 2000. Specific binding sites for an antifungal plant defensin from dahlia (Dahlia merckii) on fungal cells are required for antifungal activity. Mol. Plant-Microbe Interact. 13:54-61.
34. White, S. H., W. C. Wimley, and M. E. Selsted. 1995. Structure, function, and membrane integration of defensins. Curr. Opin. Struct. Biol. 5:521-527.
35. Wimley, W. C., M. E. Selsted, and S. H. White. 1994. Interactions between human defensins and lipid bilayers: evidence for formation of multimeric pores. Protein Sci. 3:1362-1373.
36. Wu, Z., D. M. Hoover, D. Yang. C. Boulégue, F. Santamaria, J. J. Oppenheim, J. Lubkowski, and W. Lu. Engineering disulfide bridges to dissect antimicrobial and chemotactic activities of human β-defensin-3. Proc. Natl. Acad. Sci. USA, in press.
37. Yang, D., O. Chertov, and J. J. Oppenheim. 2001. Participation of mammalian defensins and cathelicidins in anti-microbial immunity: receptors and activities of human defensins and cathelicidin (LL-37). J. Leukoc. Biol. 69:691-697.
38. Yeaman, M. R., A. S. Bayer, S. P. Koo, W. Foss, and P. M. Sullam. 1998. Platelet microbicidal proteins and neutrophil defensin disrupt the Staphylococcus aureus cytoplasmic membrane by distinct mechanisms of action. J. Clin. Investig. 101:178-187.
39. Yu, Q., R. I. Lehrer, and J. P. Tam. 2000. Engineered salt-insensitive alphadefensins with end-to-end circularized structures. J. Biol. Chem. 275:3943-3949.